Sema 5mg
Semaglutide is a long-acting glucagon-like peptide-1 (GLP-1) receptor agonist, derived from the endogenous incretin hormone GLP-1, which plays a critical role in glucose homeostasis and energy balance. Structurally, it is a synthetic peptide analog of human GLP-1 (7–37), modified to improve its pharmacokinetic profile and resistance to enzymatic degradation by dipeptidyl peptidase-4 (DPP-4).
Semaglutide is a long-acting glucagon-like peptide-1 (GLP-1) receptor agonist, derived from the endogenous incretin hormone GLP-1, which plays a critical role in glucose homeostasis and energy balance. Structurally, it is a synthetic peptide analog of human GLP-1 (7–37), modified to improve its pharmacokinetic profile and resistance to enzymatic degradation by dipeptidyl peptidase-4 (DPP-4).
Semaglutide is a long-acting glucagon-like peptide-1 (GLP-1) receptor agonist, derived from the endogenous incretin hormone GLP-1, which plays a critical role in glucose homeostasis and energy balance. Structurally, it is a synthetic peptide analog of human GLP-1 (7–37), modified to improve its pharmacokinetic profile and resistance to enzymatic degradation by dipeptidyl peptidase-4 (DPP-4).